Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 7/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.60 |
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 9/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.50 |
| ▸ | MAPT | P10636 | 8/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | HBB | P68871 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6575868 | 1.00 | MAPK1 (0.60) | MAPK1TDP1ALDH1A1CYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL15881171 | 0.98 | MAPK1 (0.63) | MAPK1TDP1ALDH1A1CYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL15881172 | 0.98 | MAPK1 (0.63) | MAPK1TDP1ALDH1A1CYP3A4TSHR | |
| SCHEMBL5720614 | 0.90 | MAPT (0.50) | MAPK1TDP1ALDH1A1CYP3A4TSHR | |
| SCHEMBL5720615 | 0.90 | MAPT (0.50) | MAPK1TDP1ALDH1A1CYP3A4TSHR | |
| SCHEMBL11649428 | 0.89 | MEN1 (0.49) | MAPK1TDP1ALDH1A1CYP3A4TSHR | |
| SCHEMBL11649424 | 0.89 | MEN1 (0.49) | MAPK1TDP1ALDH1A1CYP3A4TSHR | |
| SCHEMBL9613402 | 0.88 | MAPT (0.53) | MAPK1TDP1ALDH1A1CYP3A4TSHR | |
| SCHEMBL11684167 | 0.88 | MAPT (0.53) | MAPK1TDP1ALDH1A1CYP3A4TSHR | |
| SCHEMBL11779529 | 0.86 | KMT2A (0.56) | MAPK1TDP1ALDH1A1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10167391-B2 | Azo compound, use thereof and method for preparing same | BIONEER CORPORATION (KR) | 2019-01-01 | — | — | US | disclosed |
| US-20170016050-A1 | NOVEL AZO COMPOUND, USE THEREOF AND METHOD FOR PREPARING SAME | BIONEER CORPORATION (KR) | 2017-01-19 | — | — | US | disclosed |
| US-20170016050-A1 | NOVEL AZO COMPOUND, USE THEREOF AND METHOD FOR PREPARING SAME | BIONEER CORPORATION (KR) | 2017-01-19 | — | — | US | disclosed |
| US-20150355456-A1 | ELECTROWETTING FLUIDS | MERCK PATENT GMBH (DE) | 2015-12-10 | — | — | US | disclosed |
| WO-2014111112-A1 | ELECTROWETTING FLUIDS | MERCK PATENT GMBH (DE) | 2014-07-24 | — | — | WO | disclosed |
| EP-1152037-B1 | SQUARYLIUM COMPOUNDS AND OPTICAL RECORDING MEDIA MADE BY USING THE SAME | KYOWA HAKKO KOGYO KK (JP) | 2004-05-19 | — | — | EP | disclosed |
| US-6599605-B2 | Digital versatile disc high density recording layer | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2003-07-29 | — | — | US | disclosed |
| US-20030082329-A1 | Squarylium compounds and optical recording media using the same | KYOWA HAKKO CHEMICAL CO., LTD. (FORMERLY KYOWA YUKA CO., LTD.) (JP) | 2003-05-01 | — | — | US | disclosed |
| EP-1152037-A9 | SQUARYLIUM COMPOUNDS AND OPTICAL RECORDING MEDIA MADE BY USING THE SAME | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-02-27 | — | — | EP | disclosed |
| EP-1152037-A1 | SQUARYLIUM COMPOUNDS AND OPTICAL RECORDING MEDIA MADE BY USING THE SAME | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2001-11-07 | — | — | EP | disclosed |
| US-4225493-A | FOR POLYAMIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1980-09-30 | — | — | US | disclosed |
| US-3956264-A | Basic azo dyestuffs having indolyl-methyleneamino substituent in the diazo component | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10167391-B2 | Azo compound, use thereof and method for preparing same | CRY1, CYP51A1, CYP3A4 | MAPK1 4242/4885TDP1 3570/4885ALDH1A1 774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.